These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 14558674

  • 1. Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms.
    Guitelman M, Colombani-Vidal ME, Zylbersztein CC, Fiszlejder L, Zeller M, Levalle O, Scaglia HE.
    Pituitary; 2002; 5(4):255-60. PubMed ID: 14558674
    [Abstract] [Full Text] [Related]

  • 2. Characterization of big, big prolactin in patients with hyperprolactinaemia.
    Leite V, Cosby H, Sobrinho LG, Fresnoza MA, Santos MA, Friesen HG.
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
    [Abstract] [Full Text] [Related]

  • 3. Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus.
    García M, Colombani-Vidal ME, Zylbersztein CC, Testi A, Marcos J, Arturi A, Babini J, Scaglia HE.
    Lupus; 2004 Oct; 13(8):575-83. PubMed ID: 15462486
    [Abstract] [Full Text] [Related]

  • 4. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
    Cavaco B, Leite V, Santos MA, Arranhado E, Sobrinho LG.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2342-6. PubMed ID: 7629227
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function.
    Larrea F, Escorza A, Valero A, Hernandez L, Cravioto MC, Diaz-Sanchez V.
    J Clin Endocrinol Metab; 1989 May; 68(5):982-7. PubMed ID: 2715295
    [Abstract] [Full Text] [Related]

  • 6. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F.
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R.
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L, Naves LA, Freitas MC, Lima M, Canadas V, Albuquerque JL, Lyra R, Azevedo MF, Casulari LA.
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Prolactin variants in serum and amniotic fluid of women with ovulatory hyperprolactinemia].
    Larrea F, Escorza A, Méndez I, Ruiz JE, Valero A, Cravioto MC.
    Rev Invest Clin; 1991 Jun; 43(3):245-51. PubMed ID: 1818370
    [Abstract] [Full Text] [Related]

  • 16. Familial occurrence of big-big prolactin as the predominant immunoreactive human prolactin species in blood.
    Larrea F, Escorza A, Granados J, Valencia X, Valero A, Cravioto MC, Pérez-Palacios G.
    Fertil Steril; 1987 Jun; 47(6):956-63. PubMed ID: 3595901
    [Abstract] [Full Text] [Related]

  • 17. Bioactivity and glycosylation of circulating prolactin in various physiological and pathological conditions.
    Gambino GM, Beck-Peccoz P, Borgato S, Faglia G, Spada A, Persani L.
    Pituitary; 1999 Nov; 2(3):225-31. PubMed ID: 11081158
    [Abstract] [Full Text] [Related]

  • 18. Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance.
    Hoffmann T, Penel C, Ronin C.
    J Endocrinol Invest; 1993 Nov; 16(10):807-16. PubMed ID: 8144855
    [Abstract] [Full Text] [Related]

  • 19. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
    Kyritsi EM, Dimitriadis GK, Angelousi A, Mehta H, Shad A, Mytilinaiou M, Kaltsas G, Randeva HS.
    Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
    [Abstract] [Full Text] [Related]

  • 20. Prolactin variants in term and preterm human milk: altered structural characteristics, biological activity and immunoreactivity.
    Ellis L, Picciano MF.
    Endocr Regul; 1993 Dec; 27(4):181-92. PubMed ID: 8068895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.